CARDIOPROGRESS
Foundation for the advancement of cardiology

Right-sided mechanical valve prostheses in adults with congenital heart disease Congenital heart disease (CHD) commonly includes right-sided valvular heart disease. Patients with CHD may require multiple sternotomies and interventions in their lifetime. The longevity of their replaced valve will be one of the most important factors determining freedom from re-intervention and overall prognosis. The European Society of Cardiology Guidelines for the management of adults with CHD have recommendations as to the indications and timing of pulmonary and tricuspid valve intervention.

Atrial Fibrillation Linked to Dementia, Especially When Diagnosed Before Age 65 Years Adults with atrial fibrillation (AF) are at increased risk for dementia, especially when AF occurs before age 65 years, new research shows. Investigators note the findings highlight the importance of monitoring cognitive function in adults with AF.

AF Tied to 45% Increase in Mild Cognitive Impairment Atrial fibrillation (AF) is associated with a 45% increased risk of mild cognitive impairment (MCI), an outcome that's linked to cardiovascular risk factors and multi-comorbidity, results of a new study suggest.

COVID Coronary Plaque Infection Confirms CV Risk New evidence shows for the first time that the virus that causes COVID directly infects atherosclerotic plaques in the coronary arteries, producing a persistent inflammatory response. The findings may not only explain the link between COVID and the increased risk of cardiovascular events but mark a starting point for new therapeutic approaches.

CKD Linked to Cardiac Arrest in Hispanic, Latinx Patients Chronic kidney disease (CKD) is the strongest predictor of sudden cardiac arrest (SCA) in a population of Hispanic and Latinx patients, new data show, suggesting early identification of CKD may provide an opportunity to reduce the risk in these groups. Other predictors included heavy drinking, atrial fibrillation, coronary artery disease, heart failure and diabetes.

Ambient air pollution and maternal cardiovascular health in pregnancy Women represent a potentially susceptible group due to the delicate balance of the feto-placental circulation, rapid fetal development and tremendous physiological adaptations to the maternal cardiorespiratory system during pregnancy.

New TAVR System Promising in Pure Aortic Regurgitation Implantation of a specially designed transcatheter aortic valve replacement (TAVR) system is feasible and safe in patients with pure aortic regurgitation (AR), with no deaths and only one person needing a permanent pacemaker, a pilot first-in-human study shows.

Spreading Out Daily Meals and Snacks May Boost Heart Failure Survival Patients with heart failure (HF) who spread out the time between their first and last meal or snack of the day, regardless of daily caloric intake, may benefit with reduced risk for cardiovascular (CV) death, an observational study suggests.

Heart failure management in adults with congenital heart disease: are we on the ‘right path’? In recent years, surgical advances in the treatment of congenital heart disease (CHD) ensured a huge survival benefit. Therefore, the ageing population of adults with CHD is now frequently exposed to the long-term complications of living a long life with a deranged haemodynamics. Some groups of CHD constitute unique pathophysiological conditions, being predisposed to a wide array of undesired events in the long-term.

Transcatheter aortic valve intervention in patients with cancer The prevalence of concurrent cancer and severe aortic stenosis (AS) is increasing due to an ageing population. In addition to shared traditional risk factors for AS and cancer, patients with cancer may be at increased risk for AS due to off-target effects of cancer-related therapy, such as mediastinal radiation therapy (XRT), as well as shared non-traditional pathophysiological mechanisms.

ACC and AHA guidelines for the treatment of hypertension have been updated The target blood pressure level for adults remains below 130/80 mm Hg, but drug therapy should be initiated sooner, according to new guidelines published by the American Heart Association (AHA) and American College of Cardiology (ACC). Eleven other medical organizations endorsed the new guidelines, which replace those issued in 2017.

A new risk stratification tool A new risk stratification tool known as CA4TCH — which relies solely on clinical history — could help predict which patients with a suspected hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) will have a hypersensitivity confirmed during a drug provocation test.

New AHA Statement on Ischemia After Cardiac Surgery The American Heart Association (AHA) outlines "considerations" on the management of acute postoperative myocardial ischemia (PMI) after cardiac surgery in a scientific statement.

New ESH Hypertension Guidelines Aim for Simplified Message The European Society of Hypertension (ESH) has released updated and expanded guidelines for the management of hypertension.

The international activities of the Cardioprogress Foundation are expanding The Cardioprogress Foundation expands its international activities. A register of 7 thousand experts and an opinion of leaders from 46 countries of the world has been created.

Innovative technologies in medicine. International Congress DATS 2023 (Baku, Azerbaijan) From June 17 to June 22, 2023, the International Congress DATS 2023 was held in the capital of Azerbaijan in Baku, organized by the Tabib (State Administration for Medical Territorial Services of Azerbaijan).

WHO Advises Against Nonsugar Sweeteners for Weight Control A new guideline from the World Health Organization (WHO) on nonsugar sweeteners (NSSs) recommends not using them to control weight or reduce the risk for diabetes, heart disease, or cancer. These sweeteners include aspartame, acesulfame K, advantame, saccharine, sucralose, stevia, and stevia derivatives.

Keynote presentation «T2DM and Coronary Heart Disease». Prof Mamedov Mekhman On May 24-25, 2023, the anniversary International Heart Congress in a hybrid regime was held in Tokyo (Japan). Speakers from 25 countries of the world took part in the scientific program. The key presentation by Professor Mekhman Mamedov (Moscow, Russia) was devoted to the features of coronary artery revascularization and life prognosis in patients with diabetes mellitus and coronary heart disease. The lecture covered issues on the prevalence of diabetes in the world, the relationship with cardiovascular diseases and the prevention of complications.

European Associations Review Dietary Therapies for Obesity The European Association for the Study of Obesity (EASO) and the European Federation of the Associations of Dietitians (EFAD) have published a position statement to provide an update on evidence-based options for the medical nutrition therapy of obesity. The statement is intended for health professionals and policymakers.

Expert Discusses Which Diets Are Best, Based on the Evidence Primary care providers can draw from a wide range of diets to give patients evidence-based advice on how to lose weight, prevent diabetes, and achieve other health goals, according to a speaker at the annual meeting of the American College of Physicians (San Diego).